Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen alone can lower testosterone in some transfeminine people.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Progesterone may help trans women with breast development and health, but more research is needed.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Hormone therapies improve mental health and quality of life for those with gender dysphoria.